Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06644287
The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Advanced Soft Tissue Sarcomas
Sponsor: Ruijin Hospital
View on ClinicalTrials.gov
Summary
This study aims to investigate the value of 68Ga-grazytracer in predicting the efficacy of immunotherapy for advanced soft tissue sarcomas.
Key Details
Gender
All
Age Range
6 Years - 80 Years
Study Type
OBSERVATIONAL
Enrollment
40
Start Date
2024-10-15
Completion Date
2027-07-31
Last Updated
2024-12-13
Healthy Volunteers
No
Conditions
Locations (1)
Ruijin Hospital affiliated to Shanghai Jiao Tong University of Medicine
Shanghai, Shanghai Municipality, China